Istituto Romagnolo Per Lo Studio Dei Tumori Dino Amadori Irst S.r.l. Irccs

This study tests a radioactive drug (177Lu PSMA) in people with advanced or spreading cancers that have a specific marker called PSMA. The goal is to see if the treatment is safe and can control the disease. 83 participants will receive up to 4 cycles of the drug, with doses adju…

This study tests a new way to give radiation therapy to people with malignant pleural mesothelioma, a rare cancer of the lung lining. After surgery to remove the tumor, 30 patients receive a high dose of radiation over just 5 days using a precise machine called Tomotherapy. The g…